Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Am Acad Dermatol. 2017 Jun;76(6):1195–1197. doi: 10.1016/j.jaad.2017.01.013

Table 2.

Select outcomes for patients prescribed ER and generic minocycline

Outcome Generic Minocycline
(n=172)
Extended Release
Minocycline (n=44)
p value (α=.05)
Prescription Course 88.89% (Continue GM) 50.00% (Continue ERM) 0.001*
3.51% (Switch to
ERM)
45.45% (Switch to GM)
7.60% (Switch to other
antibiotic)
4.55% (Switch to other
antibiotic)
Median Prescription
Length
239.5 (n=172) 153.25 (n=36) 0.0563